Onfi Tablet
Product Images NDC 67386-315

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Onfi (NDC 67386-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lundbeck Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Onfi-01 (Onfi 1)

Chemical structure of clobazam showing the molecular arrangement with a chlorinated benzene ring, two ketone groups, and nitrogen atoms in a diazepine ring system.*

FDA Label Image

Onfi-08 (Onfi 10)

An instructional illustration showing a hand using a syringe to measure liquid medication from a brown glass bottle. The syringe has a blue graduated scale for accurate dosing, and an arrow indicates the direction to pull the plunger up to draw liquid into the syringe.*

FDA Label Image

Onfi-09 (Onfi 11)

An instructional image showing a hand holding a syringe-like oral dosing device being filled from a brown bottle. The plunger of the device is being pulled down to draw liquid into the syringe, with an arrow indicating the direction of plunger movement downward. No text or labeling visible.*

FDA Label Image

Onfi-10 (Onfi 12)

An instructional illustration showing a measuring device with volume markings up to 10 mL and a black ring indicating the fill level, accompanied by a dropper bottle cap positioned above it. The text instructs to "Measure to black ring." This image demonstrates how to measure an oral liquid medication accurately.*

FDA Label Image

Onfi-11 (Onfi 13)

An illustration showing a child receiving oral medication via an oral syringe. The syringe is inserted gently into the child's mouth, demonstrating the administration of a liquid dosage form by a caregiver's hand.*

FDA Label Image

Onfi-12 (Onfi 14)

Onfi (clobazam) oral suspension in a brown glass bottle with a white child-resistant cap. The label shows the product name, generic name, and strength of 2.5 mg/mL. The image depicts a hand demonstrating how to twist the bottle cap to open it. The labeler is Lundbeck Pharmaceuticals LLC.*

FDA Label Image

Logo (Onfi 15)

FDA Label Image

Ndc 67386-314-01 100 Tablets Onfi® (clobazam) Tablets 10 mg C-iv Dispense The Enclosed Medication Guide With Each Prescription. Rx Only (Onfi 16)

Packaging label for Onfi (clobazam) 10 mg tablets by Lundbeck Pharmaceuticals LLC. The label displays the product name, strength, dosage form (tablets), storage instructions, and manufacturer details. The package size indicated is 100 tablets, with a teal band highlighting the 10 mg strength. Barcode areas and NDC number 67386-314-01 are also visible.*

FDA Label Image

Ndc 67386-315-01 100 Tablets Onfi® (clobazam) Tablets 20 mg C-iv Dispense The Enclosed Medication Guide With Each Prescription. Rx Only (Onfi 17)

Packaging label for Onfi (clobazam) 20 mg tablets by Lundbeck Pharmaceuticals LLC. The label shows a box designed to hold 100 oral tablets. It includes the brand and generic name, strength, storage instructions, prescription dispensing note, and manufacturer information. There are also bar code areas and serialization details visible on the black label portion.*

FDA Label Image

Ndc 67386-313-21 120 mL Onfi® (clobazam) Oral Suspension 2.5 mg/ml C-iv For Oral Administration Only. Dispense The Enclosed Medication Guide And Instructions For Use With Each Prescription. Rx Only (Onfi 18)

Onfi (clobazam) Oral Suspension 2.5 mg/mL in a 120 mL bottle. The packaging includes dosing and storage instructions, a barcode, and mentions that the product is for oral administration only. It is labeled by Lundbeck Pharmaceuticals LLC and manufactured by Rosemont Pharmaceuticals Ltd., UK. The label also states the product is supplied with two 10 mL syringes for administration.*

FDA Label Image

Onfi-02 (Onfi 2)

A bar chart illustrating the percentage reduction in weekly drop seizure rate for Onfi (clobazam) across four groups: Placebo, Low, Medium, and High doses. The reductions increase from placebo to high dose, with the highest dose showing the greatest seizure rate reduction.*

FDA Label Image

Onfi-03 (Onfi 3)

A bar chart depicting the proportion of patients by percentage reduction in weekly drop seizure frequency from baseline. The chart compares four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High, across seizure reduction ranges including Worse, 0 to <20%, 20 to <40%, 40 to <60%, 60 to <80%, and 80 to 100%.*

FDA Label Image

Logo (Onfi 4)

FDA Label Image

Logo (Onfi 5)

FDA Label Image

Onfi-04 (Onfi 6)

Onfi (clobazam) oral suspension 2.5 mg/mL in a brown bottle with a white cap and a bottle adapter. The product includes two oral dosing syringes and a white and orange labeled carton from Lundbeck Pharmaceuticals LLC. The label indicates the suspension is for oral administration only.*

FDA Label Image

Onfi-05 (Onfi 7)

Onfi (clobazam) oral suspension bottle labeled with a dosage strength of 2.5 mg/mL. The amber glass bottle has a child-resistant white cap, and the label instructs to shake well before use. The product is manufactured by Lundbeck Pharmaceuticals LLC.*

FDA Label Image

Onfi-06 (Onfi 8)

An instructional illustration showing a close-up of a hand holding a white child-resistant cap above the neck of an amber glass bottle, with a black arrow indicating the direction to place the cap onto the bottle.*

FDA Label Image

Onfi-07 (Onfi 9)

Illustration of a dosing syringe labeled with parts including tip, dosage indicators, barrel, black ring on plunger, and plunger, used for administering liquid medication. The syringe is clear with blue measurement markings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.